Suspendisse Scelerisque Efficitur Lorem

Neuroscience, Electrophysiology, and Therapeutics Lab at BIDMC
Schizophrenia and psychosis are prevalent, debilitating conditions. Between 25 to 33% of individuals do not respond to our first line medications. In the NET Lab, we are exploring novel therapeutic modalities targeted to individuals electrophysiology based on our understanding of neuroscience to help those with schizophrenia and similar conditions.
